Private Trust Company’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,944
Closed -$490K 396
2019
Q3
$490K Buy
4,944
+95
+2% +$9.03K 0.1% 248
2019
Q2
$448K Sell
4,849
-518
-10% -$49.2K 0.09% 253
2019
Q1
$506K Sell
5,367
-878
-14% -$76.8K 0.11% 234
2018
Q4
$400K Buy
6,245
+132
+2% +$9.74K 0.1% 238
2018
Q3
$547K Buy
6,113
+244
+4% +$21.6K 0.11% 222
2018
Q2
$466K Sell
5,869
-1,841
-24% -$153K 0.1% 241
2018
Q1
$687K Sell
7,710
-2,688
-26% -$258K 0.15% 172
2017
Q4
$1.08M Sell
10,398
-4,125
-28% -$465K 0.23% 107
2017
Q3
$2.12M Sell
14,523
-4,096
-22% -$558K 0.46% 55
2017
Q2
$2.42M Sell
18,619
-704
-4% -$86.3K 0.53% 48
2017
Q1
$2.4M Buy
19,323
+1,106
+6% +$132K 0.56% 45
2016
Q4
$2.11M Sell
18,217
-1,544
-8% -$172K 0.5% 50
2016
Q3
$2.06M Sell
19,761
-4,068
-17% -$440K 0.5% 53
2016
Q2
$2.35M Sell
23,829
-96
-0.4% -$9.93K 0.61% 44
2016
Q1
$2.39M Buy
23,925
+4,572
+24% +$471K 0.65% 41
2015
Q4
$2.32M Buy
19,353
+2,280
+13% +$264K 0.66% 41
2015
Q3
$1.85M Buy
17,073
+11,645
+215% +$1.45M 0.55% 49
2015
Q2
$628K Sell
5,428
-707
-12% -$80.8K 0.18% 151
2015
Q1
$707K Sell
6,135
-462
-7% -$55.2K 0.2% 139
2014
Q4
$737K Buy
6,597
+3,144
+91% +$332K 0.23% 119
2014
Q3
$327K Sell
3,453
-139
-4% -$12.5K 0.11% 213
2014
Q2
$308K Sell
3,592
-434
-11% -$33K 0.1% 227
2014
Q1
$281K Sell
4,026
-42
-1% -$3.33K 0.11% 212
2013
Q4
$344K Buy
4,068
+400
+11% +$31.7K 0.14% 170
2013
Q3
$283K Sell
3,668
-5,142
-58% -$360K 0.13% 179
2013
Q2
$515K Buy
+8,810
New +$530K 0.24% 104

Other funds holding CELG

Private Trust Company's CELG Position: Q4 2019 in Review

Private Trust Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,944 shares — an estimated $490K sold.

Private Trust Company first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.42M in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Private Trust Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Private Trust Company sold 4,944 Celgene Corp shares in Q4 2019, an estimated $490K.
  • Private Trust Company first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Private Trust Company's Celgene Corp position peaked at $2.42M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Private Trust Company's 13F filing for Q4 2019, filed 2 Jan 2020.